发明名称 1-CYCLOPROPYL-6-FLUORO-7-(8-METHOXYIMINO-2,6-DIAZA-SPIRO[3,4]OCT-6-YL)-4-OXO-1,4-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID D-ASPARTATE HYDRATES AND AN ANTIBACTERIAL COMPOSITION COMPRISING THEIR HYDRATES
摘要 The present invention relates to 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3,4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid D-aspartate hydrates, and an antibacterial composition comprising the hydrates. The present invention provides stable zabofloxacin D-aspartate hydrates in which adsorption and desorption of water hardly occur, and provides specifically zabofloxacin D-aspartate sesquihydrate (1.5 H_2O). Because the zabofloxacin D-aspartate hydrates according to the present invention hardly absorb moisture, thereby having outstanding physicochemical properties. Therefore, the drugs comprising zabofloxacin D-aspartate hydrate of the present invention do not easily break, especially in its tablet form, and changes little in the content of the main ingredient, thus exhibiting an excellent pharmaceutical stability.
申请公布号 KR20150103916(A) 申请公布日期 2015.09.14
申请号 KR20140025565 申请日期 2014.03.04
申请人 DONG WHA PHARM. CO., LTD. 发明人 CHOI, DONG RACK;LIM, JAE KYUNG;CHANG, HWAN BONG;BAEK, NAM HYUN;KIM, SEUNG HWAN;KIM, GUN GOOK
分类号 C07D487/10;A61K31/4375;A61P31/04;C07D471/04 主分类号 C07D487/10
代理机构 代理人
主权项
地址